Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Health Affairs (Project Hope)
|
July 1, 2024
FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time
Kathleen L Miller, Ariel D Stern, Aaron Kearsley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 7, 2021
Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey
Allison R Kolbe, Aaron Kearsley, Lubna Merchant, et al.
Health Promotion International
|
February 22, 2024
A survey on perceived medication guide reading and comprehension ease among US adults
Paul R Jones, Jonas Santiago, Bryon M Pearsall, et al.
American Journal of Preventive Medicine
|
May 7, 2024
Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022
Sidney Turner, Elissa C Kranzler, Sarah Trigger, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Health Affairs (Project Hope)
|
July 1, 2024
FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time
Kathleen L Miller, Ariel D Stern, Aaron Kearsley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 7, 2021
Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey
Allison R Kolbe, Aaron Kearsley, Lubna Merchant, et al.
Health Promotion International
|
February 22, 2024
A survey on perceived medication guide reading and comprehension ease among US adults
Paul R Jones, Jonas Santiago, Bryon M Pearsall, et al.
American Journal of Preventive Medicine
|
May 7, 2024
Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022
Sidney Turner, Elissa C Kranzler, Sarah Trigger, et al.
Page
of 1